Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
40,596,743
-
Shares change
-
-682,523
-
Total reported value, excl. options
-
$2,164,481,778
-
Value change
-
-$37,427,143
-
Put/Call ratio
-
160%
-
Number of buys
-
71
-
Number of sells
-
-64
-
Price
-
$53.26
Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q3 2017
181 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q3 2017.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40,596,743 shares
of 95,963,102 outstanding shares and own 42% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,987,165 shares), Capital Research Global Investors (4,089,739 shares), BlackRock Inc. (3,762,084 shares), FMR LLC (3,657,208 shares), VANGUARD GROUP INC (3,141,018 shares), Capital International Investors (2,895,481 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,624,720 shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1,596,334 shares), STATE STREET CORP (1,515,071 shares), and PICTET ASSET MANAGEMENT LTD (750,407 shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.